Search Results

Wortmannin 25mg 25mg  | Purity Not Available

Adooq Bioscience

Wortmannin is a potent, selective, cell-permeable and irreversible inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase) (IC50 = 2 – 4 nM) which also potently inhibits polo-like kinase 1 (PLK1) (IC50 = 5.8 nM).

More Information Supplier Page

Wortmannin 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

Wortmannin is a potent, selective, cell-permeable and irreversible inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase) (IC50 = 2 – 4 nM) which also potently inhibits polo-like kinase 1 (PLK1) (IC50 = 5.8 nM).

More Information Supplier Page

Wortmannin 10mg 10mg  | Purity Not Available

Adooq Bioscience

Wortmannin is a potent, selective, cell-permeable and irreversible inhibitor of phosphatidylinositol 3-kinase (PI 3-kinase) (IC50 = 2 – 4 nM) which also potently inhibits polo-like kinase 1 (PLK1) (IC50 = 5.8 nM).

More Information Supplier Page

SL 0101-1 50mg 50mg  | Purity Not Available

Adooq Bioscience

SL 0101-1 is a selective inhibitor of p90 ribosomal S6 kinase (RSK) (IC50 = 89 nM for RSK2). It also inhibits the growth of MCF-7 human breast cancer cells with no effect on the normal breast cell line.

More Information Supplier Page

AST-1306 100mg 100mg  | Purity Not Available

Adooq Bioscience

AST-1306, a novel anilino-quinazoline compound, inhibits the enzymatic activities of wild-type epidermal growth factor receptor (EGFR) and ErbB2 as well as EGFR resistant mutant in both cell-free and cell-based systems.

More Information Supplier Page

AST-1306 10mg 10mg  | Purity Not Available

Adooq Bioscience

AST-1306, a novel anilino-quinazoline compound, inhibits the enzymatic activities of wild-type epidermal growth factor receptor (EGFR) and ErbB2 as well as EGFR resistant mutant in both cell-free and cell-based systems.

More Information Supplier Page

BMS-265246 50mg 50mg  | Purity Not Available

Adooq Bioscience

BMS-265246 is a potent new pyra- zolopyridine inhibitor of cdk2/cyclin E and cdk1/cyclin B, as well as cdk4/cyclin D.

More Information Supplier Page

BMS-265246 5mg 5mg  | Purity Not Available

Adooq Bioscience

BMS-265246 is a potent new pyra- zolopyridine inhibitor of cdk2/cyclin E and cdk1/cyclin B, as well as cdk4/cyclin D.

More Information Supplier Page

BMS-265246 100mg 100mg  | Purity Not Available

Adooq Bioscience

BMS-265246 is a potent new pyra- zolopyridine inhibitor of cdk2/cyclin E and cdk1/cyclin B, as well as cdk4/cyclin D.

More Information Supplier Page